Unknown

Dataset Information

0

Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.


ABSTRACT: Repeated oral azithromycin distribution targeted only to children has proven effective in reducing the ocular Chlamydia that causes trachoma. Here, we assess whether an enhanced coverage target of at least 90% of children is superior to the World Health Organization recommendation of at least 80%. Twenty-four trachoma-endemic communities in Matamèye, Niger, were randomized to a single day of azithromycin distribution aiming for at least 80% coverage or up to 4 days of treatment and > 90% coverage of children under age 12. All distributions were biannual. Children < 5 years of age and adults > 15 years were monitored for ocular Chlamydia infection by polymerase chain reaction every 6 months for 36 months in children and at baseline and 36 months in adults. Ocular Chlamydia prevalence in children decreased from 24.9% (95% confidence interval [CI] 15.9-33.8%) to 4.4% (95% CI 0.6-8.2%, P < 0.001) at 36 months in the standard coverage arm and from 15.6% (95% CI 10.0-21.2%) to 3.3% (95% CI 1.0-5.5%; P < 0.001) in the enhanced coverage arm. Enhanced coverage reduced ocular Chlamydia prevalence in children more quickly over time compared with standard (P = 0.04). There was no difference between arms at 36 months in children (2.4% lower with enhanced coverage, 95% CI 7.7-12.5%; P = 0.60). No infection was detected in adults at 36 months. Increasing antibiotic coverage among children from 80% to 90% may yield only short term improvements for trachoma control programs. Targeting treatment to children alone may be sufficient for trachoma control in this setting.

SUBMITTER: Oldenburg CE 

PROVIDER: S-EPMC5929194 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.

Oldenburg Catherine E CE   Amza Abdou A   Kadri Boubacar B   Nassirou Beido B   Cotter Sun Y SY   Stoller Nicole E NE   West Sheila K SK   Bailey Robin L RL   Porco Travis C TC   Gaynor Bruce D BD   Keenan Jeremy D JD   Lietman Thomas M TM  

The American journal of tropical medicine and hygiene 20171214 2


Repeated oral azithromycin distribution targeted only to children has proven effective in reducing the ocular <i>Chlamydia</i> that causes trachoma. Here, we assess whether an enhanced coverage target of at least 90% of children is superior to the World Health Organization recommendation of at least 80%. Twenty-four trachoma-endemic communities in Matamèye, Niger, were randomized to a single day of azithromycin distribution aiming for at least 80% coverage or up to 4 days of treatment and > 90%  ...[more]

Similar Datasets

| S-EPMC5845832 | biostudies-literature
| S-EPMC3757067 | biostudies-literature
| S-EPMC9399865 | biostudies-literature
| S-EPMC6550377 | biostudies-literature
| S-EPMC7789605 | biostudies-literature
| S-EPMC6592520 | biostudies-literature
| S-EPMC8719241 | biostudies-literature
| S-EPMC4161345 | biostudies-literature
| S-EPMC6889587 | biostudies-literature
| S-EPMC10724761 | biostudies-literature